1. Healthcare Providers
  2. Enroll
  3. Request Information
  4. BLOG
  5. Resources
  1. 1-800-786-7235
  2. Live Chat

about cryo-cell


Investor Relations


A healthy investment in healthier futures.

Cryo-Cell has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC QB: symbol CCEL. We specialize in stem cell preservation for family use.


Cryo-Cell Reports Third Quarter 2013 Results - 10/15/2013

OLDSMAR, Fla. – October 15, 2013 – Cryo-Cell International, Inc. (the “Company”) (OTC:QB Markets Group Symbol: CCEL), the world’s first private cord blood bank to separate and store stem cells in 1992, today announced results for the fiscal third quarter ended August 31, 2013.

David Portnoy, Cryo-Cell’s Chairman and Co-Chief Executive Officer commented, “Cryo-Cell’s fiscal third quarter 2013 results continue to show that the Company is becoming increasingly more profitable and more successful within the cord blood industry as customers choose Cryo-Cell for its superior quality and top notch service. I know Cryo-Cell has even greater potential that we will strive to realize in the coming years.”

Mark Portnoy, Cryo-Cell’s Co-Chief Executive Officer, added, “The Company’s sales and marketing initiatives have put Cryo-Cell on sounder footing, and we continue to raise the quality of our service in meaningful ways. We believe our qualitative efforts will differentiate us and have a positive impact in the future.”
more
Cryo-Cell Reports Second Quarter 2013 Results - 7/15/2013

OLDSMAR, Fla. – July 15, 2013 Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL), the world’s first private cord blood bank to separate and store stem cells in 1992, today announced results for the second quarter ended May 31, 2013. 
 
“I am pleased to report Cryo-Cell’s second quarter results for fiscal year 2013, and in particular, cash flow from operations of almost $600,000, which we believe indicates that Cryo-Cell is growing stronger day by day,” stated David Portnoy, Cryo-Cell’s Chairman and Co-CEO.  “Key metrics of performance such as the 10% increase in revenues, during the second quarter of fiscal 2013 as compared to the second quarter of fiscal 2012 are encouraging.”  Mr. Portnoy continued, “Nonrecurring expenses in the quarter relating to legacy issues included 1.) an additional accrual relating to severance payment to a former executive of $219,000, and 2.) the write-off of approximately $379,000 related to the abandonment of certain previously incurred patent expenses.”
 
Mark Portnoy, Cryo-Cell’s Co-CEO, added, “We are pleased to see the continued improvement in our business results.  The earnings from business operations in the first half of the year demonstrate that our new sales and marketing initiatives have gained traction.”

more
Cryo-Cell Reports First Quarter 2013 Results - 4/5/2013

OLDSMAR, Fla. – April 5, 2013 – Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, today announced results for the first quarter ended February 28, 2013.  
 
“I am pleased to report Cryo-Cell’s first quarter results, and in particular, cash flow from operations of slightly more than $500,000, which we believe indicates that the Cryo-Cell turnaround is well underway,” stated David Portnoy, Cryo-Cell’s Chairman and Co-CEO.  “Key metrics of performance such as the increase in revenues and the number of specimens processed of 10% and 12%, respectively, during the first quarter of fiscal 2013 as compared to the first quarter of fiscal 2012 are encouraging.”
 
Mark Portnoy, Cryo-Cell’s Co-CEO, added, “It is gratifying to see the progress the Company has made over the last year although we are still dealing with a variety of legacy issues.  With the continued execution of the new sales and marketing initiatives, I expect to see further increases in revenue and earnings.”

more



Our Partners
  • Stem Cell Research at Stanford University
  • Research Stem Cell Future Potential at University of South Florida
  • Expecting mothers please visit ACOG - American Congress of Obstetricians and Gynecologists to find cord blood collection practitioner
  • College of Nurse-Midwives supports Cord Blood Storage education
  • Florida Blood Services partner with Family Cord Blood Banks
  • National Hispanic Medical Association partners with Cryo-Cell
  • International Childbirth Education Association logo
  • Stanford University logo
  • University of Central Florida logo
  • ACOG logo
  • American College of Nurse-Midwives logo
  • Florida Blood Services partner with Family Cord Blood Banks
  • National Hispanic Medical Association logo